Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in the Human Eye-Reference-Cited by-同舟云学术

Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in the Human Eye

Published:2021-10-12 Issue: Volume: Page:1-7
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Kamalipour Alireza¹,Ashraf Mohammad Ali²³,Moghimi Sasan¹,Moattari Afagh⁴⁵,Ashraf Mohammad Javad⁶,Abbasi Farhad⁷,Azodi Farzan⁸,Oboudi Shadi³,Pirbonyeh Neda⁴⁹,Mokhtaryan Maryam¹⁰,Roshanshad Amirhossein²³,Do Jiun L.¹,Weinreb Robert N.¹

Affiliation:

1. Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California, San Diego, California, USA

2. Poostchi Ophthalmology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

3. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

4. Department of Virology and Bacteriology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

5. Bioinformatics and Computational Biology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

6. Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

7. Department of Infectious Diseases, Bushehr University of Medical Sciences, Bushehr, Iran

8. Student Research Committee, Bushehr University of Medical Sciences, Bushehr, Iran

9. Department of Microbiology, Burn and Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

10. Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Funder

Shiraz University of Medical Sciences

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2021.1980810

Reference47 articles.

1. Prevalence of Asymptomatic SARS-CoV-2 Infection

2. Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020;382(24):2327–2336. doi: 10.1056/NEJMoa2007016.

3. Rodriguez-Morales A, Cardona-Ospina J, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623. doi:10.1016/j.tmaid.2020.101623.

4. Weiss P, Murdoch D. Clinical course and mortality risk of severe COVID-19. Lancet. 2020;395(10229):1014–1015. doi: 10.1016/S0140-6736(20)30633-4.

5. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing cGAS–STING axis for therapeutic benefits in systemic lupus erythematosus;International Journal of Rheumatic Diseases;2024-07